M&T Bank
AMRX icon

M&T Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

M&T Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$289K Sell
23,256
-271
-1% -$3.64K ﹤0.01% 1388
2025
Q4 		$296K Buy
+23,527
New +$269K ﹤0.01% 1407

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

M&T Bank's AMRX Position: Q1 2026 in Review

M&T Bank reduced its Amneal Pharmaceuticals (AMRX) stake by 1.2% in Q1 2026, selling an estimated $3.64K and leaving 23,256 shares worth $289K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

M&T Bank first reported a position in AMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $296K in Q4 2025. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • M&T Bank held 23,256 shares of Amneal Pharmaceuticals worth $289K as of Q1 2026.
  • M&T Bank sold 271 Amneal Pharmaceuticals shares in Q1 2026, an estimated $3.64K.
  • Amneal Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1388 holding.
  • M&T Bank first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • M&T Bank's Amneal Pharmaceuticals position peaked at $296K in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.